Demystifying genomics for drug developers

53 minutes

Register to watch now

May 19, 2015

Register Save to Calendar

There has been an interesting shift in the reasons why pipeline drugs fail. While lack of efficacy in clinical trials has stayed about the same, 20 years ago most drugs failed because of problems related to drug metabolism and pharmacokinetics. Fast forward 10 years and now most failures are related to problems with non-clinical toxicity or clinical safety. Can genomics help solve this critical issue?

This webinar will focus on how genomics lays the foundation for precision medicine & developing the safer, more efficacious precision medicines of tomorrow. Our talk will review genomics & precision medicine foundations covering:

  • Biomarkers
  • Toxicogenomics
  • Bioinformatics

Key Learning Objectives:

By the end of this webinar you will be able to:

  • Understand expression analysis and heat maps well enough to be able to make sense of genomics experiments as reported in major medical journals
  • Appreciate that biomarkers need to be defined in the context of their use, know what a genomic biomarker signature is and be able to name at least one commercial genomic biomarker
  • Be able to remember toxicogenomics as ‘pathway based toxicology’ and understand the promise it shows in early drug development
  • Recognize the primary of bioinformatics in genomics research and biomarker development

Who Should Attend:

  • Clinical development programs- leaders and team members
  • R&D directors, managers in biotech or pharma
  • Clinical program managers or project managers
  • Companion diagnostic Specialists
  • Patient recruitment specialists
  • VP, Director of clinical operations
  • Medical science liaisons
  • Chief medical and scientific officers
  • CEO/President of pharma business unit or organization